NJ Appeals Court Revives 2K Cases In Accutane Litigation

Law360, Clifton, N.J. (July 28, 2017, 11:40 AM EDT) -- A New Jersey state appeals court on Friday revived more than 2,000 cases in consolidated litigation alleging that Hoffmann-La Roche Ltd.'s acne medication Accutane caused consumers to develop Crohn's disease, saying a trial court improperly barred testimony from plaintiffs' experts.

In a published opinion, the three-judge appellate panel reversed the lower court's 2015 rulings to bar the testimony and later dismiss the claims with prejudice, finding that the court "went beyond its gatekeeping function" at a so-called Kemp hearing and improperly assessed the experts' credibility — an issue the panel said a jury should decide.

"The trial court took too narrow...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!